Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gallic acid reduces cell growth by induction of apoptosis and reduction of IL-8 in HepG2 cells.
Lima KG, Krause GC, Schuster AD, Catarina AV, Basso BS, De Mesquita FC, Pedrazza L, Marczak ES, Martha BA, Nunes FB, Chiela ECF, Jaeger N, Thomé MP, Haute GV, Dias HB, Donadio MVF, De Oliveira JR. Lima KG, et al. Among authors: krause gc. Biomed Pharmacother. 2016 Dec;84:1282-1290. doi: 10.1016/j.biopha.2016.10.048. Epub 2016 Oct 28. Biomed Pharmacother. 2016. PMID: 27810785
Octyl gallate reduces ATP levels and Ki67 expression leading HepG2 cells to cell cycle arrest and mitochondria-mediated apoptosis.
Lima KG, Krause GC, da Silva EFG, Xavier LL, Martins LAM, Alice LM, da Luz LB, Gassen RB, Filippi-Chiela EC, Haute GV, Garcia MCR, Funchal GA, Pedrazza L, Reghelin CK, de Oliveira JR. Lima KG, et al. Among authors: krause gc. Toxicol In Vitro. 2018 Apr;48:11-25. doi: 10.1016/j.tiv.2017.12.017. Epub 2017 Dec 26. Toxicol In Vitro. 2018. PMID: 29288082
CPBMF65, a synthetic human uridine phosphorylase-1 inhibitor, reduces HepG2 cell proliferation through cell cycle arrest and senescence.
da Silva EFG, Lima KG, Krause GC, Haute GV, Pedrazza L, Catarina AV, Gassen RB, de Souza Basso B, Dias HB, Luft C, Garcia MCR, Costa BP, Antunes GL, Basso LA, Donadio MVF, Machado P, de Oliveira JR. da Silva EFG, et al. Among authors: krause gc. Invest New Drugs. 2020 Dec;38(6):1653-1663. doi: 10.1007/s10637-020-00941-2. Epub 2020 May 4. Invest New Drugs. 2020. PMID: 32367200
12 results